Listen Score
LS 26
Global Rank
TOP 10%

درباره این پادکست 🔗

میزبان‌ها:
فرکانس به روز رسانی:
every 17 days
میانگین طول صدا:
21 minutes
مصاحبه های مهمان
انگلیسی
ایالات متحده آمریکا
28 قسمت
از سال 22 ژانویه 2025
episodic

آخرین اپیزود 🔗

Generic Meds

Generic drugs save money, but do they lower the bar?  From what "bioequivalent" really requires to why an authorized generic can look just like the brand name, a lot of what gets assumed about generic drugs hasn't caught up with how tightly this corner of pharmacy is actually regulat…

جستجوی اپیزودهای گذشته

اپیزودهای قبلی Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals را جستجو کن.

اپیزود قبلی

Naloxone and nalmefene are reaching more hands than ever—through bystander programs, pharmacy dispensing protocols, and over-the-counter sales. But as access expands, one question keeps coming up: Does easier access to naloxone or nalmefene actually make opioid misuse worse? In this BONUS mailbag e…

Opioids

Opioid Rules of Thumb Are Sticky—Even When the Evidence Moves On.  From how quickly dependence risk starts to whether the newest non-opioid really replaces an opioid, a lot of advice is still running on assumptions learned years ago.  In this episode, Don and Steve separate opioid fact from folklor…
Send us Fan Mail Can polyethylene glycol (PEG 3350, Miralax) affect the absorption of other medications? In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about whether polyethylene glycol (PEG 3350) should be separated from other medications and, if so, by how long. Ho…

Laxatives

The Constipation Conversation Has Been Backed Up for Years. From fears about laxative dependence to questions about pediatric safety, some laxative myths are still stuck in the system… despite growing evidence to the contrary. In this episode, Don and Steve tackle some of the most common claims hea…
Send us Fan Mail Ivermectin continues to come up in patient conversations—and not just for adults. Can ivermectin now be used safely in all kids after the recent KIDs List update? In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about ivermectin use in kids. Hosts Don …

Ivermectin

Ivermectin Is Back in the Conversation—But What Should Healthcare Teams Know? From expanded OTC access in some states to persistent online claims, ivermectin is once again popping up in patient conversations—and bringing plenty of confusion with it. In this episode, Don and Steve dig into what’s dr…
Send us Fan Mail Gabapentin is showing up more often in veterinary care —but that raises an important question: Is gabapentin toxic in animals? In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about gabapentin use in pets. Hosts Don Weinberger, PharmD and Steve Small, …
Gabapentin has become a go-to option across a wide range of clinical scenarios—but how well does it actually hold up under closer scrutiny? In this episode, Don Weinberger and Steve Small take a closer look at how gabapentin performs in real-world use—and where expectations may not match the data. …
Send us Fan Mail  Shorter antibiotic courses are becoming the norm—but that raises an important question we hear all the time: Can patients stop antibiotics early once they start feeling better? In this BONUS mailbag episode of Rumor vs Truth, we step outside our regular format to answer a single l…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.